These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32866166)

  • 1. Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein.
    Fiolet ATL; Silvis MJM; Opstal TSJ; Bax WA; van der Horst FAL; Mosterd A; de Kleijn D; Cornel JH
    PLoS One; 2020; 15(8):e0237665. PubMed ID: 32866166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.
    Nidorf M; Thompson PL
    Am J Cardiol; 2007 Mar; 99(6):805-7. PubMed ID: 17350370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of short-term colchicine treatment on endothelial function in patients with coronary artery disease.
    Kajikawa M; Higashi Y; Tomiyama H; Maruhashi T; Kurisu S; Kihara Y; Mutoh A; Ueda SI
    Int J Cardiol; 2019 Apr; 281():35-39. PubMed ID: 30683457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Low Dose Colchicine after Myocardial Infarction (LoDoCo-MI) study: A pilot randomized placebo controlled trial of colchicine following acute myocardial infarction.
    Hennessy T; Soh L; Bowman M; Kurup R; Schultz C; Patel S; Hillis GS
    Am Heart J; 2019 Sep; 215():62-69. PubMed ID: 31284074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.
    Vaidya K; Arnott C; Martínez GJ; Ng B; McCormack S; Sullivan DR; Celermajer DS; Patel S
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):305-316. PubMed ID: 29055633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of colchicine on inflammatory markers in patients with coronary artery disease: A meta-analysis of clinical trials.
    Pan Z; Cheng J; Yang W; Chen L; Wang J
    Eur J Pharmacol; 2022 Jul; 927():175068. PubMed ID: 35644423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response.
    Akodad M; Lattuca B; Nagot N; Georgescu V; Buisson M; Cristol JP; Leclercq F; Macia JC; Gervasoni R; Cung TT; Cade S; Cransac F; Labour J; Dupuy AM; Roubille F
    Arch Cardiovasc Dis; 2017; 110(6-7):395-402. PubMed ID: 28065445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
    Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the effect of colchicine on C-reactive protein in patients with acute and chronic coronary syndromes.
    Alam M; Kontopantelis E; Mamas MA; Savinova OV; Jhaveri A; Siddiqui E; Jhamnani S
    Coron Artery Dis; 2023 May; 34(3):210-215. PubMed ID: 36762630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of C-reactive protein levels among patients with stable coronary artery disease and on statin therapy.
    Blum A; Costello R; Samsel L; Zalos G; McCoy P; Csako G; Waclawiw MA; Cannon RO
    Isr Med Assoc J; 2009 Oct; 11(10):602-5. PubMed ID: 20077946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels and values of inflammatory markers in patients with angina pectoris.
    Yip HK; Wu CJ; Hang CL; Chang HW; Yang CH; Hsieh YK; Fang CY; Fu M; Yeh KH; Chen MC
    Int Heart J; 2005 Jul; 46(4):571-81. PubMed ID: 16157948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of inflammatory markers with myocardial and microvascular injury in patients with reperfused ST-elevation myocardial infarction.
    Reindl M; Reinstadler SJ; Feistritzer HJ; Klug G; Tiller C; Mair J; Mayr A; Jaschke W; Metzler B
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):640-649. PubMed ID: 27440935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of COLchicine On-admission to Reduce inflammation in Acute Coronary Syndrome (COLOR-ACS) study.
    Toso A; Leoncini M; Magnaghi G; Biagini F; Martini O; Maioli M; Villani S; Comeglio M; Bellandi F
    J Cardiovasc Med (Hagerstown); 2023 Jan; 24(1):52-58. PubMed ID: 36473121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease.
    Roman YM; Hernandez AV; White CM
    Ann Pharmacother; 2020 Oct; 54(10):1021-1029. PubMed ID: 32425120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CPAP Does Not Reduce Inflammatory Biomarkers in Patients With Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea: A Randomized Controlled Trial.
    Thunström E; Glantz H; Yucel-Lindberg T; Lindberg K; Saygin M; Peker Y
    Sleep; 2017 Nov; 40(11):. PubMed ID: 29029237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colchicine reduces extracellular vesicle NLRP3 inflammasome protein levels in chronic coronary disease: A LoDoCo2 biomarker substudy.
    Silvis MJM; Fiolet ATL; Opstal TSJ; Dekker M; Suquilanda D; Zivkovic M; Duyvendak M; The SHK; Timmers L; Bax WA; Mosterd A; Cornel JH; de Kleijn DPV
    Atherosclerosis; 2021 Oct; 334():93-100. PubMed ID: 34492522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of low-dose colchicine in acute and chronic coronary syndromes: A systematic review and meta-analysis.
    Aimo A; Pascual Figal DA; Bayes-Genis A; Emdin M; Georgiopoulos G
    Eur J Clin Invest; 2021 Apr; 51(4):e13464. PubMed ID: 33251579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease.
    Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of markers of inflammation (C-reactive protein, fibrinogen, von Willebrand factor, and leukocyte count) and statin therapy to long-term mortality in patients with angiographically proven coronary artery disease.
    Bickel C; Rupprecht HJ; Blankenberg S; Espiniola-Klein C; Schlitt A; Rippin G; Hafner G; Treude R; Othman H; Hofmann KP; Meyer J;
    Am J Cardiol; 2002 Apr; 89(8):901-8. PubMed ID: 11950425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.